Delivery Order SPE2DB24D1021-SPE2DB24FEUAF

Award Date 9/10/24
Potential Completion Date 9/11/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of 4,565,377,763 units of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty pharmaceutical product. The order has a ceiling value of $10,886.94 and a firm fixed-price contract type. The contract does not have a set-aside designation and has an ultimate completion date of August 8, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this delivery order as...
This is a delivery order worth $8,270.95 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 4,565,664,390 units of the pharmaceutical product COSENTYX UNOREADY 300 MG PEN 2ML. The contract was awarded on September 3, 2024 and has a completion date of September 4, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of COSENTYX UNOREADY 300 MG PEN 2ML. The contract has a Firm Fixed Price pricing type and a total ceiling value of $4,828.04. The period of performance extends through January 16, 2025. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of COSENTYX UNOREADY 300 MG PEN 2ML medication. The contract has a firm fixed price of $10,900.77 and a completion date of May 21, 2025. The award is not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC provides a comprehensive global...
This is a $10,456.36 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product, with a period of performance through July 2, 2025. The award is not set-aside and represents an individual delivery order under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a $7,986.23 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML, with a completion date of June 18, 2025. The contract is a firm fixed price arrangement and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of COSENTYX UNOREADY 300 MG PEN 2ML. The contract has a firm fixed price of $8,219.11 and a completion date of May 29, 2025. The contract is not set-aside and was awarded on May 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $17,929.54. The contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product, with a performance period ending on June 17, 2025. The contract is a firm fixed-price delivery order and is not set aside for any special designations. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,210.02 firm fixed-price contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty pharmaceutical product. The contract has an ultimate completion date of October 23, 2024 and was awarded on October 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a $11,991.32 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a prescription medication. This delivery order is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides comprehensive global...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB24FEUAF
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of 4,565,751,597 units of COSENTYX UNOREADY 300 mg pen 2 ml. The contract has a firm fixed price ceiling value of $1,521.95 and an ultimate completion date of September 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the supply of a comprehensive range of pharmaceutical and medical products to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/10/24, 2:25 PM